loading

Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 0.003 0.003 -
Cost Of Revenue
-
- 0.0012 0.0012 -
Gross Profit
-
- 0.0018 0.0018 -
Operating Expenses
0.75%
1.273
1.2635 1.6623 1.8875 1.1097
Benefits Costs and Expenses
0.21%
1.2359
1.2333 1.6411 1.8571 1.0401
Costs And Expenses
0.21%
1.2359
1.2333 1.6411 1.8571 1.0401
Operating Income/Loss
0.75%
-1.273
-1.2635 -1.6605 -1.8857 -1.1097
Nonoperating Income/Loss
22.78%
0.0371
0.0302 0.0224 0.0317 0.0695
Income/Loss From Continuing Operations Before Tax
0.21%
-1.2359
-1.2333 -1.6381 -1.8541 -1.0401
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
0.21%
-1.2359
-1.2333 -1.6381 -1.8541 -1.0401
Net Income/Loss
0.21%
-1.2359
-1.2333 -1.6381 -1.8541 -1.0401
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Diluted Average Shares
0.00%
2.5805
2.5805 1.9807 - -
Diluted Earnings Per Share
0.00%
-0.48
-0.48 0.83 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):